Step 1 topics → Cardiovascular → Supraventricular Tachycardias

Supraventricular Tachycardias

USMLE Step 1 trap: Attributes an accessory bypass tract to AVNRT when it is the defining feature of AVRT. AVNRT uses two pathways within the AV node itself (slow and fast); AVRT uses the AV node plus a separate accessory pathway (e.g., Bundle of Kent) outside the node.

Supraventricular tachycardias are a group of arrhythmias originating above the bundle of His, unified by narrow-complex tachycardia on ECG (usually) and responsiveness to AV node manipulation. Students consistently apply “adenosine for SVT” as a universal rule — but giving adenosine to a patient with WPW and atrial fibrillation can precipitate ventricular fibrillation by forcing all conduction through the unregulated accessory pathway. For USMLE Step 1, you need to distinguish AVNRT from AVRT mechanistically, recognize WPW on ECG and know its lethal drug interaction, and apply the stable-vs-unstable management framework. The exam tests this at three levels: pure recall (what's a delta wave?), mechanistic application (why does adenosine work here but kill someone there?), and vignette interpretation (patient gets adenosine for AFib with WPW — what happens next?).

The trickiest part is keeping AVNRT and AVRT straight. Students blur them because both are reentrant and both involve the AV node region — but the circuit architecture is completely different. AVNRT stays entirely within the AV node (slow and fast pathways inside the node). AVRT requires an external accessory pathway like the Bundle of Kent plus the AV node as a two-limb circuit. WPW is the pre-excitation syndrome caused by that external pathway, and it shows up on ECG even in sinus rhythm as a short PR, wide QRS, and delta wave.

The highest-yield trap on USMLE Step 1 is the WPW-plus-AFib scenario. Students who memorize 'adenosine for SVT' get burned when the question adds WPW. The second trap is skipping the stability check — giving adenosine to someone who should be cardioverted immediately. Both errors are specifically constructed into question stems, so knowing the logic (not just the drug name) is what separates the correct answers.

From real student decks
78%have cards covering this topic
70%have mature cards

Common misconceptions

Common mistake
Wrong: Both AVNRT and AVRT use an accessory pathway outside the AV node as part of their reentrant circuit.
Right: AVNRT uses two pathways within the AV node itself (slow and fast); AVRT uses the AV node plus a separate accessory pathway (e.g., Bundle of Kent) outside the node.
AVNRT does not involve any accessory pathway outside the AV node — that's the defining feature of AVRT, not AVNRT. In AVNRT, the reentrant loop uses two functionally distinct pathways (slow and fast) that both exist within the AV node itself, creating a micro-reentrant circuit entirely contained at the node. In AVRT, the circuit is macro-reentrant: anterograde conduction goes down the AV node and retrograde conduction (in orthodromic AVRT) travels back up through an external bypass tract like the Bundle of Kent. Think of it this way: AVNRT is an internal AV node problem; AVRT requires a second external wire connecting atria to ventricles.
Common mistake
Wrong: AV nodal blocking agents (adenosine, beta-blockers, calcium channel blockers, digoxin) are safe to use in WPW with atrial fibrillation.
Right: In WPW with AFib, AV nodal blockers are contraindicated because blocking the AV node forces all conduction down the accessory pathway, potentially causing ventricular fibrillation; procainamide or cardioversion is used instead.
The logic here is counterintuitive but critical: when you block the AV node in WPW with AFib, you don't slow the ventricular rate — you accelerate it through the accessory pathway. The AV node normally acts as a gatekeeper that limits how fast atrial impulses reach the ventricles; the accessory pathway has no such gate. With the AV node blocked, every chaotic atrial impulse during AFib conducts rapidly and unpredictably down the accessory pathway, potentially triggering ventricular fibrillation. This is why adenosine, beta-blockers, calcium channel blockers, and digoxin are all contraindicated in WPW-AFib; procainamide (which slows accessory pathway conduction) or immediate cardioversion are the correct interventions.
Common mistake
Wrong: Adenosine should be given first for any SVT regardless of hemodynamic stability.
Right: Unstable SVT (hypotension, altered consciousness, chest pain) requires immediate synchronized cardioversion; adenosine and vagal maneuvers are reserved for stable SVT.
Adenosine is not a universal first step for SVT — hemodynamic stability must be assessed before anything else. If the patient with SVT has hypotension, altered mental status, chest pain, or signs of shock, the correct move is immediate synchronized cardioversion, not pharmacology. Delaying cardioversion to try adenosine in an unstable patient wastes critical time and can worsen the situation. The stable-then-adenosine pathway only applies when the patient is tolerating the arrhythmia — vagal maneuvers first, then adenosine IV if those fail.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Given a description of a reentrant tachycardia, identify whether the circuit involves pathways entirely within the AV node (AVNRT) versus a circuit using both the AV node and a separate external accessory pathway (AVRT) — and explain why this distinction matters mechanistically.
  2. Recognize WPW on a 12-lead ECG by its triad of short PR interval, delta wave (slurred QRS upstroke), and wide QRS — and know that in WPW with atrial fibrillation, AV nodal blocking agents are contraindicated because they can precipitate ventricular fibrillation by forcing all conduction through the unregulated accessory pathway.
  3. Apply the correct stepwise management of SVT: assess hemodynamic stability first, use synchronized cardioversion immediately for unstable patients, and reserve vagal maneuvers followed by adenosine for stable patients with narrow-complex SVT.

Can you avoid these mistakes?

A patient has narrow-complex tachycardia that terminates with adenosine. Electrophysiology study shows the reentrant circuit uses a 'slow' and 'fast' pathway, both located within the AV node. Is this AVNRT or AVRT? What would the circuit look like if it were the other diagnosis?
A 24-year-old presents with palpitations and rapid irregular wide-complex tachycardia. ECG shows delta waves during sinus rhythm. The ER resident reaches for adenosine. What is wrong with this plan, and what should be done instead?
A patient with SVT has a blood pressure of 70/40 mmHg and is confused. The nurse asks if you want to try vagal maneuvers first. What is the correct first intervention, and what class of mistake would it be to give adenosine here?
Explain in one sentence why AVRT but not AVNRT can produce a delta wave on a resting ECG — and what the delta wave physically represents in terms of ventricular activation.

Related topics

ECG Basics Heart Development and Looping Cardiac Septation Fetal Circulation and Transition Coronary Arteries and Territories

See how your Anki deck covers this topic.

Upload your deck for a free audit →